×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PGEN – precigen, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PGEN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/25
06:53 am
pgen
Precigen Is Still A Buy After The Papzimeos Rally [Seeking Alpha]
Low
Report
Precigen Is Still A Buy After The Papzimeos Rally [Seeking Alpha]
11/14
02:07 pm
pgen
Vaxart, Precigen among biotech gainers after Q3 results [Seeking Alpha]
Low
Report
Vaxart, Precigen among biotech gainers after Q3 results [Seeking Alpha]
11/14
08:09 am
pgen
Precigen (NASDAQ:PGEN) had its price target raised by analysts at HC Wainwright from $8.50 to $9.00. They now have a "buy" rating on the stock.
High
Report
Precigen (NASDAQ:PGEN) had its price target raised by analysts at HC Wainwright from $8.50 to $9.00. They now have a "buy" rating on the stock.
11/14
12:10 am
pgen
Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... [Yahoo! Finance]
High
Report
Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... [Yahoo! Finance]
11/6
05:06 pm
pgen
Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13 [Yahoo! Finance]
Low
Report
Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13 [Yahoo! Finance]
11/6
04:30 pm
pgen
Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13
Low
Report
Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13
10/16
05:39 pm
pgen
Patient Opportunity Equity Strategy Q3 2025 Portfolio Recap [Seeking Alpha]
High
Report
Patient Opportunity Equity Strategy Q3 2025 Portfolio Recap [Seeking Alpha]
10/13
07:34 am
pgen
Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis [Yahoo! Finance]
Low
Report
Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/21
08:23 pm
pgen
Form SCHEDULE 13D/A PRECIGEN, INC. Filed by: KIRK RANDAL J
Low
Report
Form SCHEDULE 13D/A PRECIGEN, INC. Filed by: KIRK RANDAL J
11/21
07:54 pm
pgen
Form 4 PRECIGEN, INC. For: Nov 19 Filed by: KIRK RANDAL J
Low
Report
Form 4 PRECIGEN, INC. For: Nov 19 Filed by: KIRK RANDAL J
11/20
05:33 pm
pgen
Form 144 PRECIGEN, INC. Filed by: KIRK RANDAL J
Low
Report
Form 144 PRECIGEN, INC. Filed by: KIRK RANDAL J
11/20
04:13 pm
pgen
Form 144/A PRECIGEN, INC. Filed by: KIRK RANDAL J
Low
Report
Form 144/A PRECIGEN, INC. Filed by: KIRK RANDAL J
11/19
05:25 pm
pgen
Form 144 PRECIGEN, INC. Filed by: KIRK RANDAL J
Medium
Report
Form 144 PRECIGEN, INC. Filed by: KIRK RANDAL J
10/30
12:50 pm
pgen
Form SCHEDULE 13G/A PRECIGEN, INC. Filed by: Patient Capital Management, LLC
Low
Report
Form SCHEDULE 13G/A PRECIGEN, INC. Filed by: Patient Capital Management, LLC
10/1
05:16 pm
pgen
Form 4 PRECIGEN, INC. For: Sep 29 Filed by: KINDLER JEFFREY B
Low
Report
Form 4 PRECIGEN, INC. For: Sep 29 Filed by: KINDLER JEFFREY B
9/30
05:44 pm
pgen
Form 4 PRECIGEN, INC. For: Sep 30 Filed by: KIRK RANDAL J
Low
Report
Form 4 PRECIGEN, INC. For: Sep 30 Filed by: KIRK RANDAL J
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/23
Form 4 PRECIGEN, INC. For: Mar 23 Filed by: Sterling Rick L.
31.6%
4/20 Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors 20.3%
3/17 Form 4 PRECIGEN, INC. For: Mar 13 Filed by: ALVAREZ CESAR L 11.6%
3/3 Form 4 PRECIGEN, INC. For: Feb 28 Filed by: KIRK RANDAL J 8.4%
4/29 Form DEFA14A PRECIGEN, INC. 5.7%
3/1 Precigen Q4 Earnings Preview [Seeking Alpha] 3.2%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: Lehr Donald P. 2.9%
2/11 Form D PRECIGEN, INC. 1.0%
4/20 Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors 20.3%
3/17 Form 4 PRECIGEN, INC. For: Mar 13 Filed by: ALVAREZ CESAR L 11.6%
3/3 Form 4 PRECIGEN, INC. For: Feb 28 Filed by: KIRK RANDAL J 8.4%
4/29 Form DEFA14A PRECIGEN, INC. 5.7%
3/1 Precigen Q4 Earnings Preview [Seeking Alpha] 3.2%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: Lehr Donald P. 2.9%
2/11 Form D PRECIGEN, INC. 1.0%
TOP News Decliners
3/20
Form 4 PRECIGEN, INC. For: Mar 19 Filed by: KIRK RANDAL J
-22.7%
3/2 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.250 ActVsEst (0.220) - Miss -17.1%
3/10 Form 4 PRECIGEN, INC. For: Mar 08 Filed by: Turley James S -7.6%
3/17 Precigen (NASDAQ: PGEN) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -5.8%
2/24 Precigen to Announce Fourth Quarter and Full Year 2019 Financial Results on March 2nd -4.6%
2/6 Form 8-K/A PRECIGEN, INC. For: Jan 31 -2.4%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: KIRK RANDAL J -2.4%
4/30 Precigen, Inc. (NASDAQ: PGEN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -1.4%
2/14 Form SC 13G PRECIGEN, INC. Filed by: MILLER VALUE PARTNERS, LLC -0.1%
3/2 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.250 ActVsEst (0.220) - Miss -17.1%
3/10 Form 4 PRECIGEN, INC. For: Mar 08 Filed by: Turley James S -7.6%
3/17 Precigen (NASDAQ: PGEN) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -5.8%
2/24 Precigen to Announce Fourth Quarter and Full Year 2019 Financial Results on March 2nd -4.6%
2/6 Form 8-K/A PRECIGEN, INC. For: Jan 31 -2.4%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: KIRK RANDAL J -2.4%
4/30 Precigen, Inc. (NASDAQ: PGEN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -1.4%
2/14 Form SC 13G PRECIGEN, INC. Filed by: MILLER VALUE PARTNERS, LLC -0.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: